65 results
Page 2 of 4
8-K
EX-99.2
8y8q7cnljbzh5f
9 Aug 22
Zentalis Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Update
12:00am
CORRESP
jgakkc
22 Jun 22
Correspondence with SEC
12:00am
UPLOAD
d1vn98 30nfr
12 May 22
Letter from SEC
12:00am
8-K
EX-99.2
pvj17z7mh6euyekz
27 Apr 22
Zentalis Pharmaceuticals Announces $25 Million Equity Investment from Pfizer
4:09pm
8-K
EX-99.2
ef1558zkds lqtkod
8 Apr 22
Zentalis Pharmaceuticals Announces Positive Initial Clinical Data on ZN-c3, its Wee1 Inhibitor, in Patients with Advanced Ovarian Cancer at AACR
5:05pm
DEF 14A
6udp3kqln1luwti3
23 Apr 21
Definitive proxy
4:05pm
10-K
p7w5qe vdkfbaqri
25 Mar 21
Annual report
7:17am
10-K
EX-10.12
38exvn
25 Mar 21
Annual report
7:17am
8-K
EX-10.1
kk7ivt 3cmix
2 Oct 20
Entry into a Material Definitive Agreement
4:51pm